Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors.

MLA

Doz, François, et al. “Phase I Dose-Escalation Study of Volasertib in Pediatric Patients with Acute Leukemia or Advanced Solid Tumors.” Pediatric Blood & Cancer, vol. 66, no. 10, Oct. 2019, p. e27900. EBSCOhost, https://doi.org/10.1002/pbc.27900.

APA

Doz, F., Locatelli, F., Baruchel, A., Blin, N., De Moerloose, B., Frappaz, D., Dworzak, M., Fischer, M., Stary, J., Fuertig, R., Riemann, K., Taube, T., & Reinhardt, D. (2019). Phase I dose-escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors. Pediatric Blood & Cancer, 66(10), e27900. https://doi.org/10.1002/pbc.27900

Chicago

Doz, François, Franco Locatelli, André Baruchel, Nicolas Blin, Barbara De Moerloose, Didier Frappaz, Michael Dworzak, et al. 2019. “Phase I Dose-Escalation Study of Volasertib in Pediatric Patients with Acute Leukemia or Advanced Solid Tumors.” Pediatric Blood & Cancer 66 (10): e27900. doi:10.1002/pbc.27900.